Asus Unveils VivoWatch 6 Plus with ECG, Blood‑Pressure Sensors and AI Wellness Coach

Why It Matters

The VivoWatch 6 Plus illustrates a shift in the wearable sector from simple activity tracking to integrated health monitoring, a transition driven by consumer interest in preventive care and the proliferation of AI analytics. By offering cuff‑less blood‑pressure measurement and an AI coach, Asus is attempting to democratize access to health insights that were previously confined to clinical settings. If successful, the device could expand the market for health‑focused wearables beyond fitness enthusiasts to a broader audience concerned with chronic disease management, sleep quality and stress reduction. Competitors may be forced to accelerate their own sensor development and AI capabilities, potentially raising the overall standard of health data quality in consumer devices.

Key Takeaways

• Asus launched the VivoWatch 6 Plus at Computex 2026, adding ECG and cuff‑less blood‑pressure sensors.
• The smartwatch features an AI‑driven wellness coach that provides personalized health recommendations.
• Battery life is projected at multiple days despite continuous health monitoring.
• The device targets everyday consumers seeking medical‑grade health insights, not just fitness enthusiasts.
• Pricing and global availability were not disclosed; shipments expected later this quarter.

Pulse Analysis

Asus’s decision to embed cuff‑less blood‑pressure tracking into the VivoWatch 6 Plus is a calculated gamble. Historically, wrist‑based blood‑pressure estimates have struggled with accuracy, leading many manufacturers to sidestep the feature. By committing to this technology, Asus signals confidence in its sensor calibration and data‑fusion algorithms, likely backed by recent advances in photoplethysmography and machine‑learning models. If the readings hold up in independent validation studies, Asus could set a new benchmark that forces rivals to prioritize similar capabilities.

The AI wellness coach also deserves scrutiny. While many wearables now offer basic insights—step counts, calorie estimates, sleep scores—Asus’s approach of delivering prescriptive advice marks a step toward true digital health coaching. The challenge lies in maintaining relevance; generic tips quickly become noise. Success will depend on the AI’s ability to adapt to individual baselines, incorporate longitudinal trends, and integrate with external health data sources such as electronic medical records. Should Asus achieve a high engagement rate, it could open a revenue stream through premium subscription services, mirroring the model pioneered by platforms like Whoop and Oura.

From a market dynamics perspective, the launch intensifies competition in a segment where Apple’s Watch Series 9 and Samsung’s Galaxy Watch 6 already dominate. Both have ECG, but neither offers reliable cuff‑less blood‑pressure measurement. Asus’s differentiation could carve out a niche among health‑conscious consumers who prioritize medical‑grade metrics over brand loyalty. However, brand perception remains a hurdle; Asus is better known for laptops and gaming hardware than for wearables. Effective marketing and third‑party clinical endorsements will be essential to overcome this bias and secure a foothold in the premium health‑wearable tier.